Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the page build; the visible study details appear unchanged.SummaryDifference0.1%

- Check14 days agoChange DetectedThe page’s revision tag has been updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This reflects an update to the page’s documentation/versioning rather than a change to trial data or study details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedNew navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added and the page revision updated to Revision: v3.6.0. The personnel attribution was adjusted, with Shen Lin appearing as a contributor and the Shen Lin, Peking University line removed.SummaryDifference2%

- Check36 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates the page content has been updated since the last revision.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer revision of the page text.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page’s “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a site/version change rather than an update to the clinical trial record.SummaryDifference0.1%

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.